Is Tumor Regression Grade Sufficient to Predict Survival in Esophageal Cancer with Trimodal Therapy?

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492. PMID: 30207593.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.21338. PMID: 26808342.
   PubMed Web of Science ®Google Scholar
• van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074–2084. PMID: 22646630. doi:10.1056/NEJMoa1112088.
   PubMed Web of Science ®Google Scholar
• Yang H, Liu H, Chen Y, et al. Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): a Phase III Multicenter, Randomized, Open-Label Clinical Trial. J Clin Ooncol. 2018;36(27):2796–2803. PMID: 30089078. doi:10.1200/JCO.2018.79.1483.
   PubMed Web of Science ®Google Scholar
• Samson P, Robinson C, Bradley J, et al. Neoadjuvant chemotherapy versus chemoradiation prior to esophagectomy: impact on rate of complete pathologic response and survival in esophageal cancer patients. J Thorac Oncol. 2016;11(12):2227–2237. PMID: 27544058. doi:10.1016/j.jtho.2016.07.031.
   PubMed Web of Science ®Google Scholar
• Hatogai K, Fujii S, Kojima T, et al. Prognostic significance of tumor regression grade for patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy followed by surgery. J Surg Oncol. 2016;113(4):390–396. PMID: 27100024. doi:10.1002/jso.24151.
   PubMed Web of Science ®Google Scholar
• Takeda FR, Tustumi F, de Almeida Obregon C, et al. Prognostic value of tumor regression grade based on ryan score in squamous cell carcinoma and adenocarcinoma of esophagus. Ann Surg Oncol. 2020;27(4):1241–1247. PMID: 31664618. doi:10.1245/s10434-019-07967-8.
   PubMed Web of Science ®Google Scholar
• Yun JK, Kim Y, Lee GD, et al. Tumor regression grade combined with lymph node status in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy. Cancer Med. 2022. doi:10.1002/cam4.4748. PMID: 35434935.
   Web of Science ®Google Scholar
• Tomasello G, Petrelli F, Ghidini M, et al. Tumor regression grade and survival after neoadjuvant treatment in gastro-esophageal cancer: a meta-analysis of 17 published studies. Eur J Surg Oncol. 2017;43(9):1607–1616. PMID: 28347525. doi:10.1016/j.ejso.2017.03.001.
   PubMed Web of Science ®Google Scholar
• Philippron A, Bollschweiler E, Kunikata A, et al. Prognostic relevance of lymph node regression after neoadjuvant chemoradiation for esophageal cancer. Semin Thorac Cardiovasc Surg. 2016;28(2):549–558. PMID: 28043475. doi:10.1053/j.semtcvs.2016.04.003.
   PubMedGoogle Scholar
• Miyata H, Tanaka K, Makino T, et al. The impact of pathological tumor regression and nodal status on survival and systemic disease in patients undergoing neoadjuvant chemotherapy for esophageal squamous cell carcinoma. Ann Surg Oncol. 2018;25(8):2409–2417. doi:10.1245/s10434-018-6507-5. PMID: 29748887.
   PubMed Web of Science ®Google Scholar
• Smyth EC, Fassan M, Cunningham D, et al. Effect of pathologic tumor response and nodal status on survival in the medical research council adjuvant gastric infusional chemotherapy trial. J Clin Oncol. 2016;34(23):2721–2727. PMID: 27298411. doi:10.1200/JCO.2015.65.7692.
   PubMed Web of Science ®Google Scholar
• Sihag S, Nobel T, Hsu M, et al. A more extensive lymphadenectomy enhances survival following neoadjuvant chemoradiotherapy in locally advanced esophageal adenocarcinoma. Ann Surg. 2020;276(2):312–317. doi:10.1097/sla.0000000000004479. PMID: 33201124.
   Web of Science ®Google Scholar
• Lutfi W, Martinez-Meehan D, Dhupar R, et al. Higher lymph node harvest in patients with a pathologic complete response after neoadjuvant therapy for esophageal cancer is associated with improved survival. J Surg Oncol. 2020;121(4):654–661. doi:10.1002/jso.25846. PMID: 31970776.
   PubMed Web of Science ®Google Scholar
• Ho HJ, Chen HS, Hung WH, et al. Survival impact of total resected lymph nodes in esophageal cancer patients with and without neoadjuvant chemoradiation. Ann Surg Oncol. 2018;25(13):3820–3832. doi:10.1245/s10434-018-6785-y. PMID: 30284131.
   PubMed Web of Science ®Google Scholar
• Semenkovich TR, Hudson JL, Subramanian M, et al. Trends in treatment of T1N0 esophageal cancer. Ann Surg. 2019;270(3):434–443. PMID: 31274653. doi:10.1097/SLA.0000000000003466.
   PubMed Web of Science ®Google Scholar
• Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer. 1994;73(11):2680–2686. PMID: 8194005. doi:10.1002/1097-0142(19940601)73:11 < 2680::aid-cncr2820731105 > 3.0.co;2-c.
   PubMed Web of Science ®Google Scholar
• Becker K, Mueller JD, Schulmacher C, et al. Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy. Cancer. 2003;98(7):1521–1530. doi:10.1002/cncr.11660. PMID: 14508841.
   PubMed Web of Science ®Google Scholar
• Ryan R, Gibbons D, Hyland JM, et al. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology. 2005;47(2):141–146. doi:10.1111/j.1365-2559.2005.02176.x. PMID: 16045774.
   PubMed Web of Science ®Google Scholar
• Swisher SG, Hofstetter W, Wu TT, et al. Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT). Ann Surg. 2005;241(5):810–817. doi:10.1097/01.sla.0000161983.82345.85. PMID: 15849517.
   PubMed Web of Science ®Google Scholar
• Japan Esophageal Society. Japanese classification of esophageal cancer. 11th edition: Part I. Esophagus. 2017;14(1):1–36. doi:10.1007/s10388-016-0551-7. PMID: 28111535.
   PubMed Web of Science ®Google Scholar
• Schneider PM, Baldus SE, Metzger R, et al. Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification. Ann Surg. 2005;242(5):684–692. PMID: 16244542. doi:10.1097/01.sla.0000186170.38348.7b.
   PubMed Web of Science ®Google Scholar